Alash’le Abimiku

Datos Biográficos

ID7016232
NOMBREAlash’le Abimiku
NOMBRESAlash’
APELLIDOle Abimiku
FIRMALE ABIMIKU A
AFILIACIONESUniversity of Maryland, Baltimore
ORCID0000-0003-2213-0204
VERIFICADOSí
TOTAL DE OBRAS10
TOTAL DE CITAS0
TOTAL COMO AUTOR10
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2009
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Advancing the course of HIV genomics research in Africa

    Open AccessFrancis E Agamah, Patrick Arbuthnot et al.ARTICLEBMJ Global Health2025

    BOX The use of genomics methods and technologies for HIV research and public health holds potential in reducing the HIV burden in sub-Saharan Africa

  • Social vulnerability index associated with higher Covid-19 seroprevalence in Nigeria

    Open AccessNatalia Blanco, Olanrewaju Lawal et al.ARTICLEGlobal Health Action2024

    Social vulnerability has been shown to be a strong predictor of disparities in health outcomes. A common approach to estimating social vulnerability is using a composite index, such as the social vulnerability index (SVI), which combines multiple factors corresponding to key social determinants of health. Lawal and Osayomi created an SVI to explore key social determinants of health-related COVID-19 infection among the Nigerian population. This st…

  • Implementation of data triangulation and dashboard development for Covid-19 vaccine adverse event following immunisation (Aefi) data in Nigeria

    Open AccessTalya Shragai, Oluwasegun Joel Adegoke et al.ARTICLEBMJ Global Health2023

    Nigeria began administering COVID-19 vaccines on 5 March 2021 and is working towards the WHO’s African regional goal to fully vaccinate 70% of their eligible population by December 2022. Nigeria’s COVID-19 vaccination information system includes a surveillance system for COVID-19 adverse events following immunisation (AEFI), but as of April 2021, AEFI data were being collected and managed by multiple groups and lacked routine analysis and use for…

  • Evaluation of the Nigeria national HIV rapid testing algorithm

    Open AccessNnaemeka C Iriemenam, Augustine Mpamugo et al.ARTICLEPLOS Global Public Health2022

    Human Immunodeficiency Virus (HIV) diagnosis remains the gateway to HIV care and treatment. However, due to changes in HIV prevalence and testing coverage across different geopolitical zones, it is crucial to evaluate the national HIV testing algorithm as false positivity due to low prevalence could be detrimental to both the client and the service delivery. Therefore, we evaluated the performance of the national HIV rapid testing algorithm using…

  • Seroprevalence of Sars-CoV-2 in four states of Nigeria in October 2020

    Open AccessRosemary Audu, Kristen A Stafford et al.ARTICLEPLOS Global Public Health2022

    The observed epidemiology of SARS-CoV-2 in sub-Saharan Africa has varied greatly from that in Europe and the United States, with much lower reported incidence. Population-based studies are needed to estimate true cumulative incidence of SARS-CoV-2 to inform public health interventions. This study estimated SARS-CoV-2 seroprevalence in four selected states in Nigeria in October 2020. We implemented a two-stage cluster sample household survey in fo…

  • Performance of HIV rapid testing algorithm in Nigeria

    Open AccessHetal K Patel, Sunday Ikpe et al.ARTICLEPLOS Global Public Health2022

    Background The Nigeria AIDS Indicator and Impact Survey (NAIIS), a cross-sectional household survey, was conducted in 2018 with primary objectives to estimate HIV prevalence, HIV-1 incidence, and status of UNAIDS 90-90-90 cascade. We conducted retrospective analysis of the performance of HIV rapid tests and the national HIV testing algorithm used in Nigeria. Methods The national algorithm included Determine HIV-1/2 as test 1 (T1), Unigold HIV-1/2…

  • Factors associated with receipt of a timely infant birth dose of hepatitis B vaccine at a tertiary hospital in North-Central Nigeria

    Open AccessFlorence Bada, Kristen A Stafford et al.ARTICLEPLOS Global Public Health2022

    The World Health Organization recommends universal vaccination of medically stable infants with Hepatitis B vaccine within 24 hours of birth to prevent mother-to-child transmission of Hepatitis B virus (HBV) infection. However, the proportion of infants who receive a timely birth dose is extremely low in Nigeria. We reviewed the implementation of an infant HBV vaccine schedule at a single center and identified factors affecting the receipt of a t…

  • A Decade of Monitoring HIV Epidemics in Nigeria

    Open AccessOluyemisi Akinwande, Adebobola Bashorun et al.ARTICLEAIDS and Behavior2016

  • HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria

    Gambo Aliyu, Mukhtar Mohammad et al.ARTICLEAIDS Care2010

    The purpose of this survey is to generate baseline data on the level of HIV infection awareness and willingness to participate (WTP) in hypothetical vaccine trials, ahead of any trial conduct in Nigeria. In a cross-sectional survey, 500 respondents were interviewed, including sex workers, male motorcycle taxi drivers, students, and the general public. About 153 (30.6%) of the respondents did not believe that correct and consistent use of condom c…

  • Social determinants of mixed feeding behavior among HIV-infected mothers in Jos, Nigeria

    Sheela Maru, Pam Datong et al.ARTICLEAIDS Care2009

    Mixed feeding confers excess risk of mother-to-child transmission (MTCT) of HIV compared with exclusive breastfeeding and exclusive formula feeding. We undertook a qualitative and quantitative cross-sectional survey to identify the social determinants of mixed feeding among a subset of the 469 HIV-infected women enrolled in a MTCT prevention program in Jos, Nigeria. Formula was provided free-of-cost. Of the 91 participants, 68 (75%) exclusively f…